3-(4-chlorophenyl)-N-{4-[2-(morpholin-4-yl)ethyl]phenyl}-4-oxo-3,4-dihydrophthalazine-1-carboxamide

ID: ALA5189718

PubChem CID: 163322235

Max Phase: Preclinical

Molecular Formula: C27H25ClN4O3

Molecular Weight: 488.98

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(CCN2CCOCC2)cc1)c1nn(-c2ccc(Cl)cc2)c(=O)c2ccccc12

Standard InChI:  InChI=1S/C27H25ClN4O3/c28-20-7-11-22(12-8-20)32-27(34)24-4-2-1-3-23(24)25(30-32)26(33)29-21-9-5-19(6-10-21)13-14-31-15-17-35-18-16-31/h1-12H,13-18H2,(H,29,33)

Standard InChI Key:  XFURMSAITSZFAY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   -2.8559   -2.6812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1413   -2.2689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4294   -2.6808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4294   -3.5060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1395   -3.9178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8559   -3.5097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7147   -2.2682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002   -2.6808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002   -3.5060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7147   -3.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7147   -4.7438    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -3.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292   -3.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1413   -3.9182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1413   -4.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4310   -5.1556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7144   -4.7473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8559   -5.1562    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7147   -1.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4294   -1.0304    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002   -1.0304    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002   -0.2052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7147    0.2075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7139    1.0302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0008    1.4429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7127    1.0337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7175    0.2090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0008    2.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7137    2.6807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7137    3.5059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4284    3.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4284    4.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7137    5.1562    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0008    4.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0008    3.9185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  1  0
  4 10  1  0
 10 11  2  0
  9 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 12 17  1  0
 15 18  1  0
  7 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 31 30  1  0
 32 31  1  0
 33 32  1  0
 34 33  1  0
 35 34  1  0
 30 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5189718

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/A02 (383 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 488.98Molecular Weight (Monoisotopic): 488.1615AlogP: 4.17#Rotatable Bonds: 6
Polar Surface Area: 76.46Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.75CX Basic pKa: 7.24CX LogP: 4.73CX LogD: 4.50
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -1.87

References

1. Shi W, Zhang P, Zou F, Zhou J, Yin Z, Cai Z, Ghaleb H, Jiang Y, Huang W, Liu Y, Qiu Q, Qian H..  (2022)  Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.,  233  [PMID:35247755] [10.1016/j.ejmech.2022.114231]

Source